TANGO THERAPEUTICS INC (TNGX) Stock Balance Sheet
NASDAQ:TNGX - Nasdaq - US87583X1090 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 58.43M | N/A | 66.39M | 60.00M | 142.70M | |||
| Marketable Securities | 158.29M | N/A | 270.50M | 306.20M | 342.50M | |||
| Receivables | N/A | N/A | 0.00 | 2.00M | 2.00M | |||
| Other Current Assets | 8.21M | 8.43M | 9.66M | 7.20M | 5.10M | |||
| Total Current Assets | 225.00M | 266.00M | 347.00M | 375.30M | 492.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 47.00M | 48.00M | 53.00M | 57.80M | 6.10M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 0.00 | 0.00 | 50.00K | 3.40M | 1.70M | |||
| Total Non-Current Assets | 49.00M | 50.00M | 56.00M | 61.20M | 7.90M | |||
| TOTAL ASSETS | 274.00M | 316.00M | 403.00M | 436.50M | 500.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 13.00M | 19.00M | 17.00M | 19.30M | 11.40M | |||
| Accounts Payable | 3.24M | 1.60M | 2.79M | 4.50M | 3.20M | |||
| Other Current Liabilities | 19.00M | 18.00M | 26.00M | 31.80M | 26.10M | |||
| Total Current Liabilities | 36.00M | 38.00M | 46.00M | 55.50M | 40.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 72.00M | 79.00M | 104.00M | 131.40M | 114.70M | |||
| Total Non-Current Liabilities | 72.00M | 79.00M | 103.00M | 131.50M | 114.70M | |||
| TOTAL LIABILITIES | 108.00M | 117.00M | 149.00M | 187.00M | 155.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -541.00M | -502.00M | -371.00M | -269.50M | -161.30M | |||
| Additional Paid In Capital | 708.00M | 701.00M | 624.00M | 522.60M | 506.80M | |||
| Common Shares | 110.00K | 110.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 190.00K | 340.00K | 190.00K | -3.70M | -800.00K | |||
| Shares Outstanding | 108.00M | 108.00M | 102.00M | 88.20M | 87.70M | |||
| Tangible Book Value per Share | 1.54 | N/A | 2.48 | 2.83 | 3.93 | |||
| Total Shareholders' Equity | 167.00M | 200.00M | 253.00M | 249.50M | 344.70M | |||
| TOTAL LIABILITIES AND EQUITY | 274.00M | 316.00M | 403.00M | 436.50M | 500.20M | |||
| Statistics | ||||||||
| Current Ratio | 6.25 | 7.00 | 7.54 | 6.76 | 12.10 | |||
| Return On Assets (ROA) | -48.54% | -41.14% | -25.31% | -24.78% | -11.64% | |||
| Return On Equity (ROE) | -79.64% | -65.00% | -40.32% | -43.36% | -16.90% | |||
All data in USD , ROIC based on taxRate of 0.21